A novel PDHK inhibitor restored cognitive dysfunction and limited neurodegeneration without affecting amyloid pathology in 5xFAD mouse, a model of Alzheimer’s disease

By sjmartinez • September 6, 2024

Sakimura K, Kawai T, Nashida R, Ishida Y, Harada K, Suzuki T, Okuma C, Cole GM. A novel PDHK inhibitor restored cognitive dysfunction and limited neurodegeneration without affecting amyloid pathology in 5xFAD mouse, a model of Alzheimer's disease. Alzheimers Res Ther. 2024 Sep 5;16(1):197. doi: 10.1186/s13195-024-01552-2. PMID: 39238036.

Tags: 5xFAD, Aerobic glycolysis, Alzheimer’s disease, Geriatrics, Glucose metabolism, GRECC, PDH, PDHK, Publications, Pyruvate dehydrogenase, Pyruvate dehydrogenase kinase, Veterans Administration

Arun S. Karlamangla, MD, PhD Appointed Chief of the UCLA Division of Geriatrics

The UCLA Department of Medicine is pleased to announce that Arun S. Karlamangla, MD, PhDhas been appointed chief of the UCLA Division of Geriatrics, effective October[...]

Improvement in the sensitivity of LA-ICP-MS bioimaging by addition of nitrogen to the argon carrier gas

Mello MG, Lockwood TE, Wanagat J, Westerhausen MT, Bishop DP. Improvement in the sensitivity of LA-ICP-MS bioimaging by addition of nitrogen to the argon carrier[...]

Experiences managing behavioral symptoms among Latino caregivers of Latino older adults with dementia and memory problems: a qualitative study

Keller MS, Guevara N, Guerrero JA, Mays AM, McCleskey SG, Reyes CE, Sarkisian CA. Experiences managing behavioral symptoms among Latino caregivers of Latino older adults[...]